ロード中...
Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/ https://ncbi.nlm.nih.gov/pubmed/27168803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|